Table 2.
Contributing factors | Considerations |
---|---|
Poor cognitive function |
Increases risk of severe hypoglycemia in patients with T2DM Severity of deficits increases the risk Greater rate of decline increases the risk |
Impaired metabolic and clearance processes |
Higher risk (vs. younger patients) for hypoglycemia-associated compromised renal function Altered drug elimination compared with younger patients Rate of insulin clearance from the circulation may decline with age Hypoglycemia counter-regulation is impaired; less efficient compensatory mechanisms to avoid hypoglycemia |
Polypharmacy |
Receiving ≥5 medication classes is associated with severe hypoglycemia In addition to sulfonylureas, angiotensin-converting enzyme inhibitors and non-selective beta-adrenoceptor antagonists can predispose to hypoglycemia |
Comorbidity | Heart failure and clinically relevant depression are predictors of hypoglycemia in elderly patients with T2DM |
Elderly patients with diabetes are at increased risk for geriatric syndromes such as polypharmacy, urinary incontinence, depression, falls, chronic pain, and cognitive impairment
T2DM type 2 diabetes mellitus